Literature DB >> 20393131

Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells.

Jie Jiang1, Hui Yu, Yan Shou, Geoffrey Neale, Sheng Zhou, Taihe Lu, Brian P Sorrentino.   

Abstract

HOXB4, a member of the Homeobox transcription factor family, promotes expansion of hematopoietic stem cells and hematopoietic progenitor cells in vivo and ex vivo when overexpressed. However, the molecular mechanisms underlying this effect are not well understood. To identify direct target genes of HOXB4 in primary murine hematopoietic progenitor cells, we induced HOXB4 function in lineage-negative murine bone marrow cells, using a tamoxifen-inducible HOXB4-ER(T2) fusion protein. Using expression microarrays, 77 probe sets were identified with differentially changed expression in early response to HOXB4 induction. Among them, we show that Hemogen (Hemgn), encoding a hematopoietic-specific nuclear protein of unknown function, is a direct transcriptional target of HOXB4. We show that HOXB4 binds to the promoter region of Hemgn both ex vivo and in vivo. When we overexpressed Hemgn in bone marrow cells, we observed that Hemgn promoted cellular expansion in liquid cultures and increased self-renewal of myeloid colony-forming units in culture, partially recapitulating the effect of HOXB4 overexpression. Furthermore, down-regulation of Hemgn using an shRNA strategy proved that Hemgn contributes to HOXB4-mediated expansion in our myeloid progenitor assays. Our results identify a functionally relevant, direct transcriptional target of HOXB4 and identify other target genes that may also participate in the HOXB4 genetic network.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393131      PMCID: PMC2918328          DOI: 10.1182/blood-2009-07-235341

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro.

Authors:  M D Milsom; R Duxbury; D Gagen; R K Humphries; M Schmidt; C von-Kalle; L J Fairbairn
Journal:  Leukemia       Date:  2005-01       Impact factor: 11.528

Review 2.  Clinical strategies for expansion of haematopoietic stem cells.

Authors:  Brian P Sorrentino
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

3.  Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells.

Authors:  Joseph T Opferman; Hiromi Iwasaki; Christy C Ong; Heikyung Suh; Shin-ichi Mizuno; Koichi Akashi; Stanley J Korsmeyer
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

4.  Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo.

Authors:  D A Persons; J A Allay; E R Allay; R J Smeyne; R A Ashmun; B P Sorrentino; A W Nienhuis
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

5.  Specificity of HOX protein function depends on DNA-protein and protein-protein interactions, both mediated by the homeo domain.

Authors:  V Zappavigna; D Sartori; F Mavilio
Journal:  Genes Dev       Date:  1994-03-15       Impact factor: 11.361

6.  Hox proteins have different affinities for a consensus DNA site that correlate with the positions of their genes on the hox cluster.

Authors:  I Pellerin; C Schnabel; K M Catron; C Abate
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

7.  EDAG regulates the proliferation and differentiation of hematopoietic cells and resists cell apoptosis through the activation of nuclear factor-kappa B.

Authors:  C Y Li; Y Q Zhan; C W Xu; W X Xu; S Y Wang; J Lv; Y Zhou; P B Yue; B Chen; X M Yang
Journal:  Cell Death Differ       Date:  2004-12       Impact factor: 15.828

8.  Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells.

Authors:  Ann C M Brun; Jon Mar Björnsson; Mattias Magnusson; Nina Larsson; Per Leveén; Mats Ehinger; Eva Nilsson; Stefan Karlsson
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

9.  Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo.

Authors:  G Sauvageau; U Thorsteinsdottir; C J Eaves; H J Lawrence; C Largman; P M Lansdorp; R K Humphries
Journal:  Genes Dev       Date:  1995-07-15       Impact factor: 11.361

10.  Alternative promoters and polyadenylation regulate tissue-specific expression of Hemogen isoforms during hematopoiesis and spermatogenesis.

Authors:  Li V Yang; Henry H Heng; Junmei Wan; Cherie M Southwood; Alexander Gow; Li Li
Journal:  Dev Dyn       Date:  2003-12       Impact factor: 3.780

View more
  17 in total

1.  Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.

Authors:  Motohiko Oshima; Mitsuhiro Endoh; Takaho A Endo; Tetsuro Toyoda; Yaeko Nakajima-Takagi; Fumihiro Sugiyama; Haruhiko Koseki; Michael Kyba; Atsushi Iwama; Mitsujiro Osawa
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

2.  Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia.

Authors:  Jasmijn D E de Rooij; Eva Beuling; Marry M van den Heuvel-Eibrink; Askar Obulkasim; André Baruchel; Jan Trka; Dirk Reinhardt; Edwin Sonneveld; Brenda E S Gibson; Rob Pieters; Martin Zimmermann; C Michel Zwaan; Maarten Fornerod
Journal:  Haematologica       Date:  2015-06-11       Impact factor: 9.941

Review 3.  The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis.

Authors:  Elizabeth Eklund
Journal:  Crit Rev Oncog       Date:  2011

4.  Hemogen/BRG1 cooperativity modulates promoter and enhancer activation during erythropoiesis.

Authors:  Xiang Guo; Yangu Zhao; Juhyun Kim; Ann Dean
Journal:  Blood       Date:  2022-06-16       Impact factor: 25.476

5.  Claudin 13, a member of the claudin family regulated in mouse stress induced erythropoiesis.

Authors:  Pamela D Thompson; Hannah Tipney; Andy Brass; Harry Noyes; Steve Kemp; Jan Naessens; May Tassabehji
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

6.  Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.

Authors:  Hui Yu; Geoffrey Neale; Hui Zhang; Han M Lee; Zhijun Ma; Sheng Zhou; Bernard G Forget; Brian P Sorrentino
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

7.  Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation.

Authors:  Aaron D Viny; Robert L Bowman; Yu Liu; Vincent-Philippe Lavallée; Shira E Eisman; Wenbin Xiao; Benjamin H Durham; Anastasia Navitski; Jane Park; Stephanie Braunstein; Besmira Alija; Abdul Karzai; Isabelle S Csete; Matthew Witkin; Elham Azizi; Timour Baslan; Christopher J Ott; Dana Pe'er; Job Dekker; Richard Koche; Ross L Levine
Journal:  Cell Stem Cell       Date:  2019-09-05       Impact factor: 24.633

8.  Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells.

Authors:  Tohru Fujiwara; Hisayuki Yokoyama; Yoko Okitsu; Mayumi Kamata; Noriko Fukuhara; Yasushi Onishi; Shinichi Fujimaki; Shinichiro Takahashi; Kenichi Ishizawa; Emery H Bresnick; Hideo Harigae
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

9.  Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.

Authors:  Elisabeth Ersvaer; Kimberley J Hatfield; Håkon Reikvam; Oystein Bruserud
Journal:  Bone Marrow Res       Date:  2010-10-04

10.  Chicken hemogen homolog is involved in the chicken-specific sex-determining mechanism.

Authors:  Tomohiro Nakata; Manabu Ishiguro; Nana Aduma; Hiroe Izumi; Asato Kuroiwa
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.